GENE ONLINE|News &
Opinion
Blog

2022-08-03| Special

Korean Companies Occupying South Korea’s Diverse Biotech Landscape

by Fujie Tham
Share To
In face of the COVID-19 pandemic, South Korea’s biotech companies have risen to the challenge of supplying the world’s vaccines, and the region is on the path to becoming one of the leading biologics manufacturers. The Korean government is actively introducing policies that favor biotech developments, such as supporting businesses to invest up to 65% of their net revenue in pharmaceutical R&Ds.

It's free! Log in now to read

LOG IN SUBSCRIBE NOW
LATEST
Vaccine Protecting Against 20 Different Pneumococcal Infections Proves Effective in Trial
2022-08-12
FDA Approves Roche’s Established Antiviral For Children Aged Five Or Older
2022-08-12
Novartis Reported Two Deaths Following Zolgensma Gene Therapy
2022-08-12
Extreme Climate Change Is Aggravating Infectious Diseases!
2022-08-11
In Response to Expanding Monkeypox Outbreak, FDA Approves Emergency Use of JYNNEOS Vaccine
2022-08-11
Potential $1 billion Acquisition of TeneoTwo by AstraZeneca comes to Fruition
2022-08-11
Gene Repair Therapy: First Patient Dosed With New Treatment for Sickle Cell Disease
2022-08-11
READ MORE
EVENT
2022-09-09
ESMO 2022 Exhibition
Online and on-side
2022-09-20
Cell & Gene Therapy USA 2022
Virtual
2022-09-21
CSCO Educational Book 2022
Xiamen
2022-09-21
RESI Boston
Boston
2022-09-26
Human Gene Therapy Conference
Australia
2022-11-07
BioFuture | Beyond Disruption: The New Age of Healthcare and Technology
New York city
SEE MORE
Newsletter
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2022 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top

Enjoy Your First 14 Days for $1.49

SUBSCRIBE NOW

Create an account with us now to say goodbye to all the pop-ups!